Back to today’s briefing

Story perspectives

Pfizer Hit with Class-Action Lawsuit Over Depo-Provera Risks

9/28/2025

38 6

Summary

Story summary

Pfizer faces a U.S. class-action lawsuit by women alleging brain tumors linked to Depo-Provera.
Plaintiffs say Pfizer failed to warn about increased meningioma risk with prolonged use.
Lawsuits total over 1,300, with estimates rising to 5,000–10,000.
A study reports a 5.6-fold higher meningioma risk for Depo-Provera users.
A Pensacola, Florida court hearing on Monday will address the claims.

1 of 1

Story summary

Pfizer faces a U.S. class-action lawsuit by women alleging brain tumors linked to Depo-Provera.
Plaintiffs say Pfizer failed to warn about increased meningioma risk with prolonged use.
Lawsuits total over 1,300, with estimates rising to 5,000–10,000.
A study reports a 5.6-fold higher meningioma risk for Depo-Provera users.
A Pensacola, Florida court hearing on Monday will address the claims.